News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
1889
Sources here
24
Companies here
26
Search results Stored financial headlines

Active search

1889 matching headlines

Ticker or company: VISMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Royal Bank of Canada Grows Position in Visteon Corporation $VC

Royal Bank of Canada significantly increased its stake in Visteon Corporation (NASDAQ:VC) by 103.2% in the first quarter, now owning 45,410 shares valued at $4.14 million. This move comes as institutional investors collectively hold 99.71% of Visteon's stock. Despite missing quarterly EPS estimates, the …

VC main company
Sharemaestro market context Trend signal active 52 weeks -12.8% · Next-week setup negative 43.1% VC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

American Century group discloses 11.8% Entravision (EVC) stake in amended report

An amended Schedule 13G/A filing reveals that American Century Investment Management, Inc., American Century Companies, Inc., and the Stowers Institute for Medical Research collectively hold an 11.8% beneficial stake in Entravision Communications Corporation (EVC), totaling 9,791,525 shares. American Century Capital Portfolios, Inc. separately holds …

EVC main company
Sharemaestro market context Trend signal active 52 weeks +282.9% · Next-week setup positive 56.3% EVC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vistagen reports Q1 FY2027: $1.48M revenue, $13.0M net loss, $31.7M cash at June 30, 2026

Vistagen announced its Q1 FY2027 results, reporting $1.476 million in revenue and a net loss of $13.03 million. The company ended the quarter with $31.7 million in cash, expecting these funds to support operations into 2027. Vistagen also highlighted upcoming FDA discussions regarding a …

VTGN main company
Sharemaestro market context Price below Trend Line 52 weeks -91.6% VTGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K VistaGen Therapeutics Inc For: 14 August By Investing.com

This article announces that VistaGen Therapeutics Inc. has filed a Form 8K on August 14th. The brief news item from Investing.com provides no further details about the content of the filing but notes the stock symbol VTGN.

VTGN main company
Sharemaestro market context Price below Trend Line 52 weeks -91.6% VTGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

Vistagen announced its fiscal year 2027 first-quarter financial results, highlighting progress in its fasedienol program for social anxiety disorder, including plans for FDA engagement regarding a Phase 3 pathway. The company reported a net loss of $13.0 million, reduced R&D and G&A expenses due …

VTGN main company
Sharemaestro market context Price below Trend Line 52 weeks -91.6% VTGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

VistaGen Therapeutics GAAP EPS of -$0.30 beats by $0.06, revenue of $1.48M beats by $1.31M

* VistaGen Therapeutics press release [https://seekingalpha.com/pr/20619736-vistagen-reports-fiscal-year-2027-first-quarter-financial-results-and-corporate-update] (VTGN [https://seekingalpha.com/symbol/VTGN]): Q1 GAAP EPS of -$0.30 beats by $0.06. * Revenue of $1.48M (+516.7% Y/Y) beats by $1.31M. * Cash, cash equivalents, and marketable securities were $31.7 million as of June 30, 2026. Based on current operating …

VTGN main company
Sharemaestro market context Price below Trend Line 52 weeks -91.6% VTGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Annovis expects October study to let Alzheimer’s patients continue treatment

Annovis (NYSE: ANVS) reported Q2 2026 results, highlighting that its pivotal Phase 3 early Alzheimer’s trial is fully enrolled with 850 patients and an open-label extension for Alzheimer's patients is planned for October 2026. The company also provided updates on its Parkinson's open-label extension, …

ANVS main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% ANVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Annovis Bio, Inc. announced significant clinical advancements and its second-quarter 2026 financial results. The company has fully enrolled its pivotal Phase 3 Alzheimer's disease trial with 850 patients, exceeding original projections, and is progressing with its Parkinson's disease open-label extension study. Annovis plans to …

ANVS main company
Sharemaestro market context Price below Trend Line 52 weeks -21.9% ANVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BBVA stock holds near recent highs as half-year profit sets a new record

BBVA stock is trading near its recent highs after the bank reported a record €6.051 billion net profit for the first half of 2026, an 11% increase year-over-year. The company also raised its return-on-tangible-equity target to 21% for the full year. Despite a consensus …

BBVA main company
Sharemaestro market context Trend signal active 52 weeks +57.5% · Next-week setup positive 65.1% BBVA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Vista Energy (VIST) buys back 50,000 Series A shares for MXN 56.7M

Vista Energy, S.A.B. de C.V. (VIST) announced the repurchase of 50,000 Series A shares on August 13, 2026, for approximately MXN 56.7 million, excluding fees and VAT. The shares were bought back at a price of MXN 1,133.76 per share under an authorization from …

VIST main company
Sharemaestro market context Trend signal active 52 weeks +69.4% VIST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Assenagon Asset Management S.A. Makes New Investment in Vishay Precision Group, Inc. $VPG

Assenagon Asset Management S.A. has initiated a new position in Vishay Precision Group (VPG), acquiring 18,144 shares valued at approximately $2.72 million. This investment comes amidst mixed analyst sentiment for VPG, which holds a "Moderate Buy" consensus rating but recently reported earnings and revenue …

VPG main company
Sharemaestro market context Trend signal active 52 weeks +153.6% VPG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

5 Insightful Analyst Questions From Envista’s Q2 Earnings Call

5 Insightful Analyst Questions From Envista's Q2 Earnings Call Envista's second quarter results were shaped by balanced growth across all major geographies and a continued focus on operational execution. Management pointed to resilient demand for dental care, especially in consumables and diagnostics, as a …

NVST main company
Sharemaestro market context Trend signal started 52 weeks +29.2% NVST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

National Vision Holdings, Inc. (NASDAQ:EYE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

National Vision Holdings, Inc. (NASDAQ:EYE) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $30.36, significantly above its current trading price. The company recently surpassed quarterly earnings and revenue estimates, reporting $0.25 EPS against an $0.18 consensus …

EYE main company
Sharemaestro market context Price below Trend Line 52 weeks -22.3% EYE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ziff Davis (ZD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Financial Officer - Bret RichterChief Executive Officer - Vivek Shah TAKEAWAYS Revenue -- $286.7 million, representing a 2.7% decrease across four reportable segments compared to the prior year.Adjusted …

ZD main company
Sharemaestro market context Trend signal active 52 weeks +44.9% ZD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ziff Davis CAO Lori Tansley sells $76,664 in company stock

Lori A. Tansley, Chief Accounting Officer at Ziff Davis, Inc. (NASDAQ:ZD), sold 1,400 shares of company stock for $76,664 on August 12, 2026. This insider sale occurred while Ziff Davis stock was trading near its 52-week high, following an 83% surge in the past …

ZD main company
Sharemaestro market context Trend signal active 52 weeks +44.9% ZD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update

CapsoVision, Inc. has released its Q2 2026 financial results, highlighting significant inventory growth, increased total assets, and a decrease in cash and cash equivalents. The medical device firm, classified as a non-accelerated filer, reported 50,046,913 shares outstanding and provided forward-looking statements regarding its operations …

CV main company
Sharemaestro market context Trend signal active 52 weeks +61.5% · Next-week setup negative 35.5% CV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Visa’s Stablecoin Settlement Push Might Change The Case For Investing In Visa (V)

Lithic, Zerohash, and Cashi recently announced new partnerships and products that use Visa's network to enable USDC and other stablecoin settlement, cross-border payouts via Visa Direct, and everyday card spending from stablecoin balances. Visa's own onchain analytics show stablecoins processed US$4.80 trillion in the …

V main company V main company VISA34 main company V main company VISA main company
Sharemaestro market context Trend signal active 52 weeks +22.6% V stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission

Earnings Call Insights: CapsoVision, Inc. (CV) Q2 2026 MANAGEMENT VIEW * “The second quarter represented another period of steady progress for CapsoVision as we continued executing our commercial strategy while advancing several important initiatives across our product portfolio,” said (Co-Founder, President, CEO & Director …

CV main company
Sharemaestro market context Trend signal active 52 weeks +61.5% · Next-week setup negative 35.5% CV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CapsoVision Q2 Earnings Call Highlights

Key Points Interested in CapsoVision, Inc.? Here are five stocks we like better. Second-quarter revenue rose 10% to $3.6 million, driven by a 13% increase in CapsoCam Plus capsule sales and shipments of 8,845 units. More than 176,000 patients worldwide have now used the …

CV main company
Sharemaestro market context Trend signal active 52 weeks +61.5% · Next-week setup negative 35.5% CV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MicroVision Announces Launch of Proposed Public Offering

MicroVision, Inc. (NASDAQ: MVIS) has announced the commencement of a public offering consisting of units, each containing one share of common stock (or pre-funded warrant) and one warrant to purchase an additional share of common stock. WestPark Capital, Inc. is acting as the exclusive …

MVIS main company
Sharemaestro market context Price below Trend Line 52 weeks -86.5% MVIS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lori Tansley Sells 1,400 Shares of Ziff Davis (NASDAQ:ZD) Stock

Lori Tansley, Chief Accounting Officer of Ziff Davis (NASDAQ:ZD), sold 1,400 shares of company stock on August 12th, 2026, for a total of $76,664. Following this transaction, her holdings decreased by 64.61% to 767 shares. The company recently reported strong quarterly earnings, beating analyst …

ZD main company
Sharemaestro market context Trend signal active 52 weeks +44.9% ZD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CapsoVision Files Mixed Shelf for Up to $250 Million in Securities

CapsoVision, Inc. has filed a mixed shelf registration for up to $250 million in securities, as reported on August 13, 2026. This financial move allows the company flexibility in raising capital through various securities offerings in the future. The announcement coincides with other recent …

CV main company
Sharemaestro market context Trend signal active 52 weeks +61.5% · Next-week setup negative 35.5% CV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context